John K. Fraser,Marc H. Hedrick,Min Zhu,Brian M. Strem,Eric Daniels,Isabella Wulur
申请号：
US11138083
公开号：
US09597395B2
申请日:
2005.05.25
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Adipose derived regenerative cells are used to treat patients, including patients with cardiovascular conditions, diseases or disorders. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of regenerative cells, e.g., stem and/or progenitor cells, obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the stem cells are not exposed to an external environment prior to being administered to a patient. Accordingly, in a preferred method, adipose derived regenerative cells are placed directly into a recipient along with such additives necessary to promote, engender or support a therapeutic cardiovascular benefit.
